SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER? -- Ignore unavailable to you. Want to Upgrade?


To: Tupulak who wrote (110)6/6/2000 4:51:00 AM
From: blue_chip  Respond to of 164
 
NEWS

ONC (Toronto Stock Exchange) is 40% owned by Synsorb, full release at thenextwave.emerchantpro.com

Regards
Chip

FOR: ONCOLYTICS BIOTECH INC.

TSE, CDNX SYMBOL: ONC

JUNE 6, 2000

Oncolytics Biotech Inc. Announces Initiation of REOLYSIN
Clinical Study

CALGARY, ALBERTA--Oncolytics Biotech Inc. ("Oncolytics" or "the
Company") (TSE:ONC, CDNX:ONC) today announced that it has
initiated its first clinical study examining the use of REOLYSIN
in patients with cancer.